|

Melphalan Hydrochloride Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Alkeran, Alkerana, Evomela, Hepzato

Pipeline

Phase 3: 1

Top Sponsors

  • Children's Oncology Group1

Indications

  • Ganglioneuroblastoma, Nodular1
  • Ganglioneuroblastoma1
  • Neuroblastoma1
  • Cancer1

Birmingham, Alabama1 trial

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Children's Hospital of Alabama

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.